News
Submitted New Drug Application for vepdegestrant for the treatment of ESR1m, ER+/HER2- advanced or metastatic breast cancer – ...
STNE, CVS, KT, KB, and USNA stand out as low P/B stocks with strong EPS growth prospects for August portfolios.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback